Literature DB >> 16125131

Bromination and chlorination reactions of myeloperoxidase at physiological concentrations of bromide and chloride.

Revathy Senthilmohan1, Anthony J Kettle.   

Abstract

Myeloperoxidase and eosinophil peroxidase use hydrogen peroxide to oxidize halides and thiocyanate to their respective hypohalous acids. Myeloperoxidase produces mainly hypochlorous acid and hypothiocyanite. Hypobromous acid and hypothiocyanite are the major products of eosinophil peroxidase. We have investigated the ability of myeloperoxidase to produce hypobromous acid in the presence of physiological concentrations of chloride and bromide. In accord with previous studies, between pH 5 and 7, myeloperoxidase converted about 90% of available hydrogen peroxide to hypochlorous acid and the remainder to hypobromous acid. Above pH 7, there was an abrupt rise in the yield of hypobromous acid. At pH 7.8, it accounted for 40% of the hydrogen peroxide. Bromide, at physiological concentrations, promoted a dramatic increase in bromination of human serum albumin catalyzed by myeloperoxidase. The level of 3-bromotyrosine increased to 16-fold greater than that for 3-chlorotyrosine. Chlorination of tyrosyl residues was not affected by bromide. With reagent hypohalous acids, bromination of tyrosyl residues was considerably more facile than chlorination. Hypochlorous acid promoted bromination to only a limited extent, which ruled out transhalogenation as a substantive route to 3-bromotyrosine. Chloramines and bromamines were also formed on albumin. Bromamines decayed much faster than chloramines and rapidly gave rise to protein carbonyls. We conclude that at physiological concentrations of chloride and bromide, hypobromous acid can be a major oxidant produced by myeloperoxidase. Its production in vivo will depend on pH and the concentration of bromide. Once produced, hypobromous acid will react with proteins to form bromamines, carbonyls, and brominated tyrosine residues. Consequently, 3-bromotyrosine should be considered as an oxidative product of myeloperoxidase and cannot be used as a specific biomarker for eosinophil peroxidase.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16125131     DOI: 10.1016/j.abb.2005.07.005

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  34 in total

1.  Simultaneous identification of tyrosine phosphorylation and sulfation sites utilizing tyrosine-specific bromination.

Authors:  Jong-Seo Kim; Si-Uk Song; Hie-Joon Kim
Journal:  J Am Soc Mass Spectrom       Date:  2011-07-29       Impact factor: 3.109

2.  Synthesis and antioxidant properties of an unnatural plasmalogen analogue bearing a trans O-vinyl ether linkage.

Authors:  Ravi S Lankalapalli; Joseph T Eckelkamp; Debajit Sircar; David A Ford; Papasani V Subbaiah; Robert Bittman
Journal:  Org Lett       Date:  2009-07-02       Impact factor: 6.005

Review 3.  Nox enzymes in immune cells.

Authors:  William M Nauseef
Journal:  Semin Immunopathol       Date:  2008-05-01       Impact factor: 9.623

4.  The Ancient Immunoglobulin Domains of Peroxidasin Are Required to Form Sulfilimine Cross-links in Collagen IV.

Authors:  Isi A Ero-Tolliver; Billy G Hudson; Gautam Bhave
Journal:  J Biol Chem       Date:  2015-07-15       Impact factor: 5.157

5.  Analytical validation of fecal 3-bromotyrosine concentrations in healthy dogs and dogs with chronic enteropathy.

Authors:  Panpicha Sattasathuchana; Naris Thengchaisri; Jan S Suchodolski; Jonathan A Lidbury; Jörg M Steiner
Journal:  J Vet Diagn Invest       Date:  2019-02-15       Impact factor: 1.279

6.  Degradation of extracellular matrix and its components by hypobromous acid.

Authors:  Martin D Rees; Tane N McNiven; Michael J Davies
Journal:  Biochem J       Date:  2007-01-15       Impact factor: 3.857

7.  Kinetic investigation of myeloperoxidase upon interaction with copper, cadmium, and lead ions.

Authors:  Maryam Shabani; Mohsen Ani; Ahmad Movahedian; Seyed Ziyae Aldin Samsam Shariat
Journal:  Iran Biomed J       Date:  2011

8.  Myeloperoxidase-derived oxidants selectively disrupt the protein core of the heparan sulfate proteoglycan perlecan.

Authors:  Martin D Rees; John M Whitelock; Ernst Malle; Christine Y Chuang; Renato V Iozzo; Anastasia Nilasaroya; Michael J Davies
Journal:  Matrix Biol       Date:  2009-09-27       Impact factor: 11.583

9.  A halotyrosine antibody that detects increased protein modifications in asthma patients.

Authors:  Hongjun Jin; Teal S Hallstrand; Don S Daly; Melissa M Matzke; Parameswaran Nair; Diana J Bigelow; Joel G Pounds; Richard C Zangar
Journal:  J Immunol Methods       Date:  2013-12-02       Impact factor: 2.303

10.  Quantification of Modified Tyrosines in Healthy and Diabetic Human Urine using Liquid Chromatography/Tandem Mass Spectrometry.

Authors:  Yoji Kato; Natsuko Dozaki; Toshiyuki Nakamura; Noritoshi Kitamoto; Akihiro Yoshida; Michitaka Naito; Masayasu Kitamura; Toshihiko Osawa
Journal:  J Clin Biochem Nutr       Date:  2008-12-27       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.